Panbela Therapeutics, Inc. Debt Conversion, Converted Instrument, Amount
Panbela Therapeutics, Inc. reported Debt Conversion, Converted Instrument, Amount of $3.30 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2018-11-05
- Panbela Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2018-09-30 was $0.00.
- Panbela Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2015-12-31 was $0.00.
- Panbela Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $226.00K, a 123.76% increase from fiscal 2014.
- Panbela Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2014 was $101.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $3.30M 10-Q · filed 2018-11-05 | ||
| 2018-06-30 | $3.30M 10-Q · filed 2018-08-13 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $226.00K 10-K · filed 2017-03-30 | ||
| 2015-09-30 | $226.00K 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $101.00K 10-K · filed 2016-03-08 |